Skip to main content
. 2014 Feb 10;3(2):376–384. doi: 10.1002/cam4.199

Figure 3.

Figure 3

Effect of p53 expression on the survival in the human papillomavirus (HPV) DNA-positive group and in the HPV DNA-negative group. (A) Cumulative survival in patients with HPV DNA-positive metastases with absent-intermediary/low (0–60%) and high (90–100%) p53 expression. (B) Cumulative survival in patients with HPV DNA-negative metastases with absent-intermediary/low (0–60%) and high (90–100%) p53 expression.